Ischemic diffusion lesion reversal is uncommon and rarely alters perfusion-diffusion mismatch

被引:92
作者
Chemmanam, T. [1 ,2 ,4 ]
Campbell, B. C. V. [1 ,2 ,3 ]
Christensen, S. [3 ]
Nagakane, Y. [5 ]
Desmond, P. M. [3 ]
Bladin, C. F. [4 ]
Parsons, M. W. [6 ,7 ]
Levi, C. R. [6 ,7 ]
Barber, P. A. [8 ]
Donnan, G. A. [5 ]
Davis, S. M. [1 ,2 ]
机构
[1] Univ Melbourne, Royal Melbourne Hosp, Dept Neurol, Parkville, Vic 3050, Australia
[2] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Parkville, Vic 3050, Australia
[3] Univ Melbourne, Royal Melbourne Hosp, Dept Radiol, Parkville, Vic 3050, Australia
[4] Monash Univ, Box Hill Hosp, Dept Neurol, Melbourne, Vic, Australia
[5] Univ Melbourne, Florey Neurosci Inst, Melbourne, Vic 3010, Australia
[6] Univ Newcastle, John Hunter Hosp, Dept Neurol, Callaghan, NSW 2308, Australia
[7] Univ Newcastle, John Hunter Hosp, Hunter Med Res Inst, Callaghan, NSW 2308, Australia
[8] Univ Auckland, Dept Neurol, Auckland 1, New Zealand
基金
英国医学研究理事会;
关键词
WEIGHTED MRI LESIONS; FINAL INFARCT VOLUME; CEREBRAL INFARCT; ACUTE STROKE; H; THROMBOLYSIS; COEFFICIENT; EVOLUTION; PREDICT; DEFUSE;
D O I
10.1212/WNL.0b013e3181f39ab6
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: The use of diffusion-weighted imaging (DWI) to define irreversibly damaged infarct core is challenged by data suggesting potential partial reversal of DWI abnormalities. However, previous studies have not considered infarct involution. We investigated the prevalence of DWI lesion reversal in the EPITHET Trial. Methods: EPITHET randomized patients 3-6 hours from onset of acute ischemic stroke to tissue plasminogen activator (tPA) or placebo. Pretreatment DWI and day 90 T2-weighted images were coregistered. Apparent reversal of the acute ischemic lesion was defined as DWI lesion not incorporated into the final infarct. Voxels of CSF at follow-up were subtracted from regions of apparent DWI lesion reversal to adjust for infarct atrophy. All cases were visually cross-checked to exclude volume loss and coregistration inaccuracies. Results: In 60 patients, apparent reversal involved a median 46% of the baseline DWI lesion (median volume 4.9 mL, interquartile range 2.6-9.5 mL) and was associated with less severe baseline hypoperfusion (p < 0.001). Apparent reversal was increased by reperfusion, regardless of the severity of baseline hypoperfusion (p = 0.02). However, the median volume of apparent reversal was reduced by 45% when CSF voxels were subtracted (2.7 mL, interquartile range 1.6-6.2 mL, p < 0.001). Perfusion-diffusion mismatch classification only rarely altered after adjusting the baseline DWI volume for apparent reversal. Visual comparison of acute DWI to subacute DWI or day 90 T2 identified minor regions of true DWI lesion reversal in only 6 of 93 patients. Conclusions: True DWI lesion reversal is uncommon in ischemic stroke patients. The volume of apparent lesion reversal is small and would rarely affect treatment decisions based on perfusion-diffusion mismatch. Neurology (R) 2010;75:1040-1047
引用
收藏
页码:1040 / 1047
页数:8
相关论文
共 30 条
  • [1] Magnetic resonance imaging profiles predict clinical response to early reperfusion: The diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study
    Albers, Gregory W.
    Thijs, Vincent N.
    Wechsle, Lawrence
    Kemp, Stephanie
    Schlaug, Gottfried
    Skalabrin, Elaine
    Bammer, Roland
    Kakuda, Wataru
    Lansberg, Maarten G.
    Shuaib, Ashfaq
    Coplin, William
    Hamilton, Scott
    Moseley, Michael
    Marks, Michael P.
    [J]. ANNALS OF NEUROLOGY, 2006, 60 (05) : 508 - 517
  • [2] Prediction of stroke outcome with echoplanar perfusion- and diffusion-weighted MRI
    Barber, PA
    Darby, DG
    Desmond, PM
    Yang, Q
    Gerraty, RP
    Jolley, D
    Donnan, GA
    Tress, BM
    Davis, SM
    [J]. NEUROLOGY, 1998, 51 (02) : 418 - 426
  • [3] BURGER PC, 1978, AM J PATHOL, V92, P253
  • [4] CHRISTENSEN S, 2010, STROKE, V41, pE44
  • [5] Selection of thrombolytic therapy beyond 3 h using magnetic resonance imaging
    Davis, SM
    Donnan, GA
    Butcher, KS
    Parsons, M
    [J]. CURRENT OPINION IN NEUROLOGY, 2005, 18 (01) : 47 - 52
  • [6] Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial
    Davis, Stephen M.
    Donnan, Geoffrey A.
    Parsons, Mark W.
    Levi, Christopher
    Butcher, Kenneth S.
    Peeters, Andre
    Barber, P. Alan
    Bladin, Christopher
    De Silva, Deidre A.
    Byrnes, Graham
    Chalk, Jonathan B.
    Fink, John N.
    Kimber, Thomas E.
    Schultz, David
    Hand, Peter J.
    Frayne, Judith
    Hankey, Graeme
    Muir, Keith
    Gerraty, Richard
    Tress, Brian M.
    Desmond, Patricia M.
    [J]. LANCET NEUROLOGY, 2008, 7 (04) : 299 - 309
  • [7] Desmond PM, 2001, AM J NEURORADIOL, V22, P1260
  • [8] Breaking the 3 h barrier for treatment of acute ischaemic stroke
    Donnan, Geoffrey A.
    Davis, Stephen M.
    [J]. LANCET NEUROLOGY, 2008, 7 (11) : 981 - 982
  • [9] Expediting MRI-Based Proof-of-Concept Stroke Trials Using an Earlier Imaging End Point
    Ebinger, Martin
    Christensen, Soren
    De Silva, Deidre A.
    Parsons, Mark W.
    Levi, Christopher R.
    Butcher, Kenneth S.
    Bladin, Christopher F.
    Barber, P. Alan
    Donnan, Geoffrey A.
    Davis, Stephen M.
    [J]. STROKE, 2009, 40 (04) : 1353 - 1358
  • [10] Severe ADC decreases do not predict irreversible tissue damage in humans
    Fiehler, J
    Foth, M
    Kucinski, T
    Knab, R
    von Bezold, M
    Weiller, C
    Zeumer, H
    Röther, J
    [J]. STROKE, 2002, 33 (01) : 79 - 86